What are you RAMPERS on about! Phase 1b recruiting hasn't started yet. It says in the RNS "The US trial sites will initially contribute patients to the dose escalation phase, while being uniquely positioned to lead the enrolment of soft tissue sarcoma patients in the phase 1b dose expansion stage of the AVA6000 study when this begins"
Although I'm sure Dr Tap has a huge list of potential participants.
As per the nature article you would think that they would be very close to getting approaches now. Things would get more expensive with the phase 1b progressing and being designed more like a phase 2 efficacy demonstration.